PETALING JAYA: Delays in receiving the second dose of the Pfizer-BioNTech Covid-19 vaccine may slow the optimum build-up of antibodies, says Tan Sri Dr Noor Hisham Abdullah (pic).
“The drastic increase in the antibody’s ability to provide effectiveness for a person in the long-term is after the second dose.
Already a subscriber? Log in
Get 20% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
